drugset / Trial / NCT00744848

Study to Evaluate Postoperative Analgesia in Subjects Undergoing Hemorrhoidectomy

NCT00744848

Phase 3 Completed 204 enrolled Pacira Pharmaceuticals, Inc
RandomizedParallel-groupDouble-blindSupportive care

Summary

Effective postoperative pain control to promote improved healing, faster patient mobilization, shortened hospital stays, and reduced healthcare costs.

Timeline

Start
2008-08
Primary completion
2009-02
Completion
2009-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified 100 mg Other
Subject SKY0402 Unknown 300 mg Other

Indications